Blog Standard

Kan & Krishme Secures Favorable Delhi High Court Order in Pharmaceutical Patent Appeal

We are pleased to share that our team at Kan & Krishme successfully represented Chia Tai Tianqing Pharmaceutical Group Co. Ltd. before the Hon’ble High Court of Delhi in C.A.(COMM.IPD-PAT) 52/2024. By its order dated May 15, 2026, the Hon’ble Court set aside the Patent Office’s refusal of Patent Application No. 202117022431, titled-‘TRIFLUOROMETHYL-SUBSTITUTED SULFONAMIDE AS […]
Read more
AI in Advertising: ASCI’s New Draft Disclosure Guidelines

AI in Advertising: ASCI’s New Draft Disclosure Guidelines

Overview The Advertising Standards Council of India (ASCI) has released draft guidelines requiring brands to disclose the use of Artificial Intelligence in advertising. The framework is risk-based: it does not ban AI, but it mandates transparency wherever AI-generated content could materially influence consumer decisions. These guidelines align with the Information Technology (Intermediary Guidelines and Digital […]
Read more

Reach us at knk@kankrishme.com

X